Meyka Pro banner
Aclarion, Inc.

Aclarion, Inc. Fundamental Analysis (NASDAQ: ACONW)

ACONWNASDAQ
HealthcareMedical - Healthcare Information Services
$0.03
$0.005(21.95%)
U.S. Market opens in 3h 4m

Aclarion, Inc. Fundamental Analysis (NASDAQ: ACONW)

Aclarion, Inc. (NASDAQ: ACONW) shows weak financial fundamentals with a PE ratio of -0.31, profit margin of -109.78%, and ROE of -59.34%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position22047.23%
PEG Ratio-0.00
Current Ratio16.20

Areas of Concern

ROE-59.34%
Operating Margin-115.92%
We analyze ACONW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -10335.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-10335.2/100

We analyze ACONW's fundamental strength across five key dimensions:

Efficiency Score

Weak

ACONW struggles to generate sufficient returns from assets.

ROA > 10%
-50.98%

Valuation Score

Excellent

ACONW trades at attractive valuation levels.

PE < 25
-0.31
PEG Ratio < 2
-0.00

Growth Score

Weak

ACONW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ACONW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
16.20

Profitability Score

Weak

ACONW struggles to sustain strong margins.

ROE > 15%
-5933.95%
Net Margin ≥ 15%
-109.78%
Positive Free Cash Flow
No

Key Financial Metrics

Is ACONW Expensive or Cheap?

P/E Ratio

ACONW trades at -0.31 times earnings. This suggests potential undervaluation.

-0.31

PEG Ratio

When adjusting for growth, ACONW's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Aclarion, Inc. at 0.34 times its book value. This may indicate undervaluation.

0.34

EV/EBITDA

Enterprise value stands at -1.96 times EBITDA. This is generally considered low.

-1.96

How Well Does ACONW Make Money?

Net Profit Margin

For every $100 in sales, Aclarion, Inc. keeps $-109.78 as profit after all expenses.

-109.78%

Operating Margin

Core operations generate -115.92 in profit for every $100 in revenue, before interest and taxes.

-115.92%

ROE

Management delivers $-59.34 in profit for every $100 of shareholder equity.

-59.34%

ROA

Aclarion, Inc. generates $-50.98 in profit for every $100 in assets, demonstrating efficient asset deployment.

-50.98%

Following the Money - Real Cash Generation

Operating Cash Flow

Aclarion, Inc. generates limited operating cash flow of $-1.75M, signaling weaker underlying cash strength.

$-1.75M

Free Cash Flow

Aclarion, Inc. generates weak or negative free cash flow of $-1.75M, restricting financial flexibility.

$-1.75M

FCF Per Share

Each share generates $-3.28 in free cash annually.

$-3.28

FCF Yield

ACONW converts -6.37% of its market value into free cash.

-6.37%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.31

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.34

vs 25 benchmark

P/S Ratio

Price to sales ratio

15.15

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

16.20

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.59

vs 25 benchmark

ROA

Return on assets percentage

-0.51

vs 25 benchmark

ROCE

Return on capital employed

-0.57

vs 25 benchmark

How ACONW Stacks Against Its Sector Peers

MetricACONW ValueSector AveragePerformance
P/E Ratio-0.3131.50 Better (Cheaper)
ROE-59.34%422.00% Weak
Net Margin-10978.48%19867.00% Weak
Debt/Equity0.000.53 Strong (Low Leverage)
Current Ratio16.205.56 Strong Liquidity
ROA-50.98%1571.00% Weak

ACONW outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aclarion, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ